Introduction: Hepatocellular carcinoma is the fifth most common cancer worldwide and the second leading cause of cancer-related death. More than 7 lakh people die of HCC each year1,2. Imaging and histopathology plays a very important role in the diagnosis of HCC.
Introduction
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the second leading cause of cancer-related death. More than 7 lakh people die of HCC each year 1,2. It occurs primarily in subjects who have chronic liver disease or liver cirrhosis 3 and is the primary cause of death among this group. The high-risk group includes patients testing positive for Hepatitis B, Hepatitis C, or those suffering with cirrhosis 4 . HCC usually occurs in the setting of cirrhosis3, although this is not always the case, with the classic example being HCC associated with hepatitis B in the noncirrhotic liver. Several imaging diagnostic systems have been proposed for the interpretation of liver lesions in at-risk patients for HCC. Although these imaging-based diagnostic systems represent important advances, they have limitations and they are not perfectly consistent with each other 5 . Unfortunately, despite numerous http://jmscr.igmpublication.org/home/ ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v7i8.38 technological developments and improvements in recent years, the diagnostic accuracy of noninvasive imaging in patients with cirrhosis is still relatively low, ranging respectively between 0.60 and 0.72 for USG, between 0.74 and 0.83 for MDCT and between0.71 and 0.87 for MRI [6] [7] [8] [9] [10] [11] [12] [13] . The relatively poor diagnostic performance for the detection of HCC in cirrhotic liver is due principally to overlapping imaging features and, thus, difficulties in differentiating dysplastic nodules from small HCC, and to problems associated with diagnosing arterially enhancing nodules smaller than 2 cm in diameter. For these reasons patients generally undergo regular followup with CT or MRI.
Aims and Objectives
1) To study the radiological behaviour of HCC 2) To study the incidence of specific imaging features on Ultrasound, MDCT and MRI in pathologically proven cases of Hepatocellular carcinoma. 
Materials and Methods

Results
The youngest patient diagnosed with HCC in our study is 25 years and the oldest is 81 years. The average age of the patient at diagnosis is 54 years. Majority of the cases occurred in the age group of 51-60 years (38.88%), followed by 61-70 years (25%) and 41-50 years ( 
Discussion
HCC can occur in a wide range of age groups including young patients. This is in contrast to the general opinion that HCC is a disease of the adults and elderly. The youngest patient in our study is 25 years old. The average age at diagnosis is 54 years. Cirrhosis is a known risk factor for the development of HCC, which is reflected in our study with 52.78% of the study group being cirrhotic. A male preponderance is noted with the disease, probably due to other risk factors like alcoholism, that predispose to Cirrhosis and eventually HCC. Hepatomegaly was observed with 55.56% of the cases, which doesn't correlate with the size of the tumour or with the no. of lesions. Majority of the lesions studied measure between 5-10 cm in largest dimension, shown by 18 lesions, corresponding to 50%. 8 lesions (22.22%) measured < 5 cm and 7 lesions (19.44%) measured 10-15 cm. The average size of the lesion is 7.986 cm in largest dimension. Of the 36 lesions studied, 25 lesions (69.44%)are hyperechoic, 9 lesions (25%) are mixed echogenic and 2 lesions (5.56%) are predominantly hypoechoic.
Intralesional vascularity is seen in 83.33%, as detected by color doppler. Intralesional necrosis is noted in 41.67% of the cases which occurs when the tumour outgrows its vascular supply. Karahan OI 14 showed that the portal vein thrombosis was more frequently associated with lesions larger than 10 cm, whereas in our study, portal vein thrombosis was seen in the tumour sizes ranging from 4.4 cm to 10 cm. Peri-lesional halo could be demonstrated in 26 cases, corresponding to 72.22%. Of all the lesions studied, no lesion showed intra lesional calcification, which is in contradiction to several studies, which found an incidence of intralesional calcifications, ranging from 3-25% 15, 16 . In this study, 35 lesions (97.22%) showed enhancement in arterial phase and one lesion showed no enhancement (2.78%). Venous phase washout was seen in 32 of the 35 lesions that showed enhancement in the arterial phase, corresponding to 91.43%. While 3 lesions, corresponding to 8.57% did not show washout in the venous phase. These findings, are in close agreement with the findings made by K.H.Y. Lee (2003) 17 , who have found that hypervascular component was seen in 96% of the cases, 86% of the lesions showed arterial phase enhancement and 76% of the lesions showed washout in the venous phase. Baron 
Conclusion
HCC can present over a wide range of age groups and can have a wide spectrum of radiological appearances. Hence, no single feature can be pathognomonic of the diagnosis. However, the most consistent findings in our study include: USG: hyperechoic mass lesion with intralesional vascularity and a peripheral halo. CECT: lesion showing enhancement in the arterial phase and washout in the venous phase with a well-defined capsule that enhances in the delayed phase and showing mosaic architecture. MRI: T1 hypo intensity, T2 hyperintensity, with mosaic architecture. Biochemistry: Elevated AFP with deranged LFTs. However, a tissue diagnosis is always desirable, whenever there is high index of suspicion, in lesions showing atypical pattern of imaging features.
